moclobemide has been researched along with Phobia, Social in 2 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Phobia, Social: Anxiety disorder characterized by the persistent and irrational fear, anxiety, or avoidance of social or performance situations.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doruyter, A | 2 |
| Dupont, P | 2 |
| Taljaard, L | 1 |
| Stein, DJ | 2 |
| Lochner, C | 2 |
| Warwick, JM | 2 |
| Jordaan, GP | 1 |
2 other studies available for moclobemide and Phobia, Social
| Article | Year |
|---|---|
Resting regional brain metabolism in social anxiety disorder and the effect of moclobemide therapy.
Topics: Adult; Anxiety Disorders; Brain; Brain Mapping; Female; Humans; Magnetic Resonance Imaging; Male; Mi | 2018 |
Resting functional connectivity in social anxiety disorder and the effect of pharmacotherapy.
Topics: Adult; Antidepressive Agents; Brain; Citalopram; Emotions; Female; Gyrus Cinguli; Humans; Male; Mocl | 2016 |